While gastric acid-reducing medications (ARMs) such as proton pump inhibitors (PPIs) and histamine-2 receptor antagonists ...

INDIANA — Federal health regulators and major retailers are urging consumers to check their medicine cabinets following a ...

ORR and 70% CRc in venetoclax-naïve and 48% ORR and 24% CRc in venetoclax-experienced patients at the recommended 600 mg once ...

C-BEYOND Phase 3 North American Trial for Treatment of Hepatitis C Virus (HCV) Remains on Track with Topline Results Expected Mid-2026C-FORWARD ...

Earnings call Cinclus Pharma delivered strong operational progress in Q1 2026, highlighted by near-complete enrollment in its pivotal HEEALING 1 phase III trial and robust financial flexibility with a ...

For patients taking GLP-1 receptor agonists (GLP-1 RAs), the use of proton pump inhibitors (PPIs) is associated with an increased risk for gastrointestinal (GI) adverse effects, according to research ...

Dear Dr. Roach: I read in your column that you test your patient’s magnesium levels when they have been on long-term proton-pump inhibitors (PPIs). When I asked my doctor to include this in his order ...

US Producer Price Index (PPI) Final Demand jumped 6% in April 2026, the highest reading since January 2023. The print came in well above the 4.9% consensus forecast. The monthly gain hit 1.4%, nearly ...

Dear Dr. Roach: I recently read in your column that you test your patient's magnesium levels when they have been on long-term proton-pump inhibitors (PPIs). When I asked my doctor to include this in ...

The producer price index rose a seasonally adjusted 1.4% for the month, much higher than the 0.5% Dow Jones consensus forecast and the upwardly revised 0.7% March increase. Energy was at the root of ...

KOMZIFTI™ (ziftomenib) net product revenue in first full quarter of commercialization –– Robust new patient starts and early ...